A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum.

PubWeight™: 2.62‹?› | Rank: Top 1%

🔗 View Article (PMID 4546706)

Published in Clin Chim Acta on July 31, 1974

Authors

M A Preece, J L O'Riordan, D E Lawson, E Kodicek

Articles citing this

Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97

Combined deficiency of iron and vitamin D in Asian toddlers. Arch Dis Child (1986) 3.18

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest (2005) 1.96

Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ (1992) 1.95

Policy for prevention of Asian rickets in Britain: a preliminary assessment of the Glasgow rickets campaign. Br Med J (Clin Res Ed) (1981) 1.83

Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J (1979) 1.58

Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest (1986) 1.55

Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation. J Clin Endocrinol Metab (2011) 1.55

Vitamin D nutrition in pregnant women at term and in newly born babies in Saudi Arabia. J Clin Pathol (1984) 1.44

Clinical and subclinical vitamin D deficiency in Bradford children. Arch Dis Child (1976) 1.41

Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr (2008) 1.29

Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest (1993) 1.12

Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr (2010) 1.01

Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. J Clin Invest (1989) 1.01

Persisting vitamin D deficiency in the Asian adolescent. Arch Dis Child (1984) 1.01

Vitamin D Deficiency and Its Health Consequences in Africa. Clin Rev Bone Miner Metab (2009) 1.00

Commercially available sun lamps and vitamin D formation. Postgrad Med J (1981) 0.97

Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int (2015) 0.94

Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest (1993) 0.92

Vitamin D deficiency and low osteocalcin concentrations in anorexia nervosa. J Clin Pathol (1988) 0.91

Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis. Thorax (1988) 0.90

Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women. Osteoporos Int (2008) 0.87

Effect of supplemental vitamin D and calcium on serum sclerostin levels. Eur J Endocrinol (2014) 0.84

Vitamin D nutrition in pregnant Nigerian women at term and their newborn infants. J Clin Pathol (1986) 0.83

Serum sclerostin levels vary with season. J Clin Endocrinol Metab (2013) 0.83

Low vitamin D levels have become less common in primary hyperparathyroidism. Osteoporos Int (2015) 0.83

Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major. Arch Dis Child (1987) 0.79

Vitamin D status after resection of ileum in childhood. Arch Dis Child (1975) 0.77

Osteomalacia associated with increased renal tubular resorption of phosphate (hypohyperparathyroidism). Postgrad Med J (1976) 0.75

Articles by these authors

Body mass index reference curves for the UK, 1990. Arch Dis Child (1995) 16.96

Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child (1995) 12.65

British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med (1998) 10.09

Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ (2000) 5.71

Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature (1970) 5.66

Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42

"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet (1992) 3.74

The structure of bactoprenol, a lipid formed by lactobacilli from mevalonic acid. Biochem J (1966) 3.33

Vitamin-D deficiency among Asian immigrants to Britain. Lancet (1973) 3.26

Studies of vitamin D deficiency in man. Q J Med (1975) 2.94

Growth curve for girls with Turner syndrome. Arch Dis Child (1985) 2.88

Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ (1991) 2.69

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet (2002) 2.68

The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria. J Med Genet (1999) 2.63

Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature (1971) 2.58

Vitamin methods: 7. A new modification of the p-aminoacetophenone method for estimating nicotinic acid in urine. Biochem J (1943) 2.40

A new family of mathematical models describing the human growth curve. Ann Hum Biol (1978) 2.34

Parathyroid venous sampling: anatomic considerations and results in 95 patients with primary hyperparathyroidism. Br J Radiol (1980) 2.29

Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet (1986) 2.20

Immunoradiometric assay of parathyroid hormone. J Endocrinol (1971) 2.19

Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J (1979) 2.02

Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab (1967) 2.00

Competitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Mol Med (1974) 2.00

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia. Lancet (1983) 2.00

Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nat New Biol (1973) 2.00

Increase in length of leg relative to trunk in Japanese children and adults from 1957 to 1977: comparison with British and with Japanese Americans. Ann Hum Biol (1982) 1.93

Isolation and chemical properties of porcine parathyroid hormone. Biochemistry (1971) 1.92

Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-1, in chick intestinal nuclei. Biochem J (1969) 1.85

Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp Brain Res (1989) 1.77

1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet (1979) 1.71

Human 27-kDa calbindin complementary DNA sequence. Evolutionary and functional implications. Eur J Biochem (1987) 1.68

Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet (1997) 1.64

Corticotrophin-secreting carcinomas. Q J Med (1966) 1.64

Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet (1985) 1.61

Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr (1995) 1.59

Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency. Arch Dis Child (1999) 1.54

Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med (1989) 1.52

Sex differences in weight in infancy. Published centile charts for weights have been updated. BMJ (1996) 1.52

Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr (1981) 1.49

Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation? Arch Dis Child (1991) 1.49

Prevention of vitamin-D deficiency in Asians. Lancet (1976) 1.45

Insulin-dependent diabetes mellitus presenting with ketoalkalosis in Rett syndrome. Diabet Med (1997) 1.44

Silver-Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions. J Med Genet (2001) 1.43

Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab (1999) 1.43

1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure. Lancet (1973) 1.43

Clinical and subclinical vitamin D deficiency in Bradford children. Arch Dis Child (1976) 1.41

Stabilizing feedbacks in glacier-bed erosion. Nature (2003) 1.40

Successful pregnancy in a patient with type III glycogen storage disease managed with cornstarch supplements. Br J Obstet Gynaecol (1998) 1.40

Vitamin D status in different subgroups of British Asians. Br Med J (1976) 1.40

Growth reference charts for use in the United Kingdom. Arch Dis Child (2002) 1.39

The 3-M syndrome. J Med Genet (1984) 1.37

The amino-acid sequence of the amino-terminal 37 residues of human parathyroid hormone. Proc Natl Acad Sci U S A (1974) 1.37

The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth. J Pediatr Endocrinol Metab (2001) 1.35

The prediction of total body water using bioelectrical impedance in children and adolescents. Ann Hum Biol (1988) 1.35

The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child (2006) 1.33

Vitamin D deficiency in mothers of rachitic infants. Calcif Tissue Int (1984) 1.33

Growth in atopic eczema: a controlled study by questionnaire. Arch Dis Child (1989) 1.32

Metabolism of tritiated vitamin D. Proc R Soc Lond B Biol Sci (1966) 1.31

Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay. Clin Endocrinol (Oxf) (1980) 1.29

Hypoplastic optic nerves and pituitary dysfunction. A spectrum of anatomical and endocrine abnormalities. Arch Dis Child (1984) 1.29

Biological activity of a polar metabolite of vitamin D. Nature (1970) 1.28

The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure. Clin Sci (1972) 1.27

Secretion of parathyroid hormone in primary hyperparathyroidism. Clin Endocrinol (Oxf) (1972) 1.27

The lipids of paramyxoviruses: a comparative study of Sendai and Newcastle disease viruses. Virology (1968) 1.26

Dose dependence of growth response to human growth hormone in growth hormone deficiency. J Clin Endocrinol Metab (1976) 1.25

Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syndrome. Am J Hum Genet (2000) 1.25

The metabolism of niacytin in the rat. Trigonelline as a major metabolite of niacytin in the urine. Biochem J (1970) 1.23

Egg and breast milk based nitrogen sources compared. Arch Dis Child (1989) 1.23

The metabolism of niacytin in the rat. Studies of the excretion of nicotinic acid metabolites. Biochem J (1970) 1.22

A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Sci Mol Med (1978) 1.22

Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am J Respir Crit Care Med (1994) 1.21

New vitamin D metabolite localized in intestinal cell nuclei. Nature (1969) 1.20

Hydroxylysine in the N-terminal regions of the 1 - and 2 -chains of various collagens. Biochem J (1971) 1.20

Immunohistochemical mapping of vitamin D-dependent calcium-binding protein in brain. Nature (1981) 1.20

New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland. Arch Dis Child (2002) 1.20

Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology (1987) 1.20

The response of the small intestine to vitamin D. Isolation and properties of chick intestinal polyribosomes. Biochem J (1974) 1.19

Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology (1986) 1.19

Adolescent growth and pubertal progression in the Silver-Russell syndrome. Arch Dis Child (1988) 1.18

A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK. J Med Genet (1998) 1.18

Production and properties of vitamin-D-induced mRNA for chick calcium-binding protein. Eur J Biochem (1976) 1.18

Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J Med Genet (1995) 1.17

Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC. J Inherit Metab Dis (2003) 1.17

Isolation of chick intestinal nuclei. Effect of vitamin D3 on nuclear metabolism. Biochem J (1969) 1.16

A longitudinal study of the growth in height of boys and girls of West Bengal (India) aged six months of 20 years. Ann Hum Biol (1981) 1.16

The amino acid sequence of porcine parathyroid hormone. Biochemistry (1974) 1.16

Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Q J Med (1970) 1.15

Growth prognosis and growth after menarche in primary hypothyroidism. Arch Dis Child (1991) 1.15

Structure-function studies in parathyroid hormone. Proc R Soc Med (1971) 1.15